ENZN

Enzon Pharmaceuticals, Inc. Competitors

$1.27
*  
0.07
5.83%
Get ENZN Alerts
*Delayed - data as of Jul. 1, 2015  -  Find a broker to begin trading ENZN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ENZN After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Competitor Industry: Biotechnology: Biological Products (No Diagnostic Substances)

Enzon Pharmaceuticals, Inc.

CompanyName
Symbol: Market
LastSale NetChange Volume Today's High / Low 52 Weeks High / Low P / E Ratio Market Cap
Biogen Inc.
BIIB: NASDAQ-GS
$ 405.41 1.47 ▲ 992,526 $ 409.98
$ 404.375
$ 480.18
$ 290.85
29.25 95,364,594,300
Amgen Inc.
AMGN: NASDAQ-GS
$ 154.99 1.47 ▲ 2,299,413 $ 155.75
$ 153.43
$ 173.60
$ 114.93
20.92 117,842,616,760
Bio-Techne Corp
TECH: NASDAQ-GS
$ 97.54 -0.93 ▼ 195,697 $ 99.11
$ 97.02
$ 103.56
$ 86.01
33.63 3,623,903,620
Gilead Sciences, Inc.
GILD: NASDAQ-GS
$ 116.01 -1.07 ▼ 10,246,999 $ 118.60
$ 115.40
$ 123.37
$ 83.32
13.17 170,488,992,060
China Biologic Products, Inc.
CBPO: NASDAQ-GS
$ 113.44 -1.72 ▼ 68,277 $ 116.76
$ 112.55
$ 121.22
$ 43.2101
39.12 2,819,891,520
Spark Therapeutics, Inc.
ONCE: NASDAQ-GS
$ 59.76 -0.51 ▼ 127,471 $ 61.99
$ 59.02
$ 79.50
$ 40.16
NE 1,466,749,440
Juno Therapeutics, Inc.
JUNO: NASDAQ-GS
$ 54.45 1.12 ▲ 5,977,913 $ 55.38
$ 51.33
$ 69.28
$ 34.71
NE 4,923,695,700
Cellectis S.A.
CLLS: NASDAQ-GM
$ 34.99 -1.09 ▼ 167,647 $ 36.75
$ 34.33
$ 50
$ 30.40
NE 1,153,585,310
Seattle Genetics, Inc.
SGEN: NASDAQ-GS
$ 47.82 -0.58 ▼ 789,638 $ 48.915
$ 46.985
$ 49.84
$ 30.05
NE 5,972,096,340
bluebird bio, Inc.
BLUE: NASDAQ-GS
$ 163.07 -5.30 ▼ 841,312 $ 170.69
$ 162.41
$ 197.35
$ 29.73
NE 5,353,425,030
Acorda Therapeutics, Inc.
ACOR: NASDAQ-GS
$ 32.09 -1.24 ▼ 801,209 $ 33.83
$ 31.935
$ 45.45
$ 28.26
97.24 1,373,163,190
Acceleron Pharma Inc.
XLRN: NASDAQ-GM
$ 30.02 -1.62 ▼ 209,519 $ 32.14
$ 29.70
$ 48.50
$ 23.61
NE 985,016,240
Kite Pharma, Inc.
KITE: NASDAQ-GS
$ 63.50 2.53 ▲ 2,031,804 $ 63.91
$ 60.40
$ 89.21
$ 21
NE 2,734,246,500
Qiagen N.V.
QGEN: NASDAQ-GS
$ 25.15 0.36 ▲ 948,215 $ 25.24
$ 25.03
$ 25.91
$ 20.73
53.51 5,853,335,550
DBV Technologies S.A.
DBVT: NASDAQ-GS
$ 30.40 0.62 ▲ 293,541 $ 32.49
$ 30.12
$ 30.04
$ 20.2601
NE 1,177,848,000
Repligen Corporation
RGEN: NASDAQ-GS
$ 41.21 -0.06 ▼ 203,681 $ 41.85
$ 40.77
$ 42.48
$ 18.23
196.24 1,353,830,920
Avalanche Biotechnologies, Inc.
AAVL: NASDAQ-GM
$ 16.07 -0.17 ▼ 573,095 $ 16.61
$ 16
$ 62.48
$ 15.03
NE 410,251,030
Applied Genetic Technologies Corporation
AGTC: NASDAQ-GM
$ 16.26 0.92 ▲ 100,546 $ 16.59
$ 15.53
$ 28.24
$ 14.40
NE 267,346,920
Adaptimmune Therapeutics plc
ADAP: NASDAQ-GS
$ 17.558 -0.77 ▼ 475,646 $ 18.8399
$ 17.18
$ 21.57
$ 13.75
NE 1,209,921,780
Cidara Therapeutics, Inc.
CDTX: NASDAQ-GM
$ 14.66 0.64 ▲ 38,813 $ 14.97
$ 13.92
$ 19.13
$ 13.34
NE 198,071,260
aTyr Pharma, Inc.
LIFE: NASDAQ-GS
$ 17 -1.52 ▼ 99,092 $ 18.79
$ 16.60
$ 28.29
$ 12.90
NE 401,795,000
Neurocrine Biosciences, Inc.
NBIX: NASDAQ-GS
$ 47.66 -0.10 ▼ 651,525 $ 48.89
$ 47.16
$ 49.49
$ 12.6325
NE 4,071,021,880
Coherus BioSciences, Inc.
CHRS: NASDAQ-GM
$ 29.84 0.94 ▲ 287,484 $ 29.90
$ 28.69
$ 33.30
$ 12.27
NE 1,129,175,440
Osiris Therapeutics, Inc.
OSIR: NASDAQ-GM
$ 19.56 0.10 ▲ 152,208 $ 20.07
$ 19.15
$ 20.70
$ 11.87
652 672,668,400
Cellular Biomedicine Group, Inc.
CBMG: NASDAQ-GM
$ 38.40 0.89 ▲ 103,001 $ 38.74
$ 37.1901
$ 49
$ 11.5001
NE 422,208,000